• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

11
8
3
3
3

COUNTRY

11
3
1

CATEGORIES

  • 21
  • 12
  • 5
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL…

PRICE

5
9
22
30

PUBLISHED

1
1
5
30

PRODUCT TYPE

24
4
2

Search "Hospira Generics Company Intelligence Report" returned 30 results.

PRODUCT TITLE

Generic Growth Strategies - Market Driven by Impending Patent Cliff, Declining R&D Productivity and Government Initiatives to Reduce Healthcare Costs

Generic Growth Strategies - Market Driven by Impending Patent Cliff, Declining R&D Productivity and Government Initiatives to Reduce Healthcare Costs Summary GBI Research, the leading business intelligence...

December 2012
FROM

Hospira Inc - SWOT, Strategy and Corporate Finance Report

Hospira Inc - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and...

January 2013
FROM

Hospira, Inc. (HSP) - Product Pipeline Analysis, 2014 Update

Summary Hospira, Inc. (Hospira) is a global specialty pharmaceutical and medication delivery company. The company undertakes the development, manufacturing, and marketing of products that help improve...

July 2014
FROM
The Pharmaceutical Market: USA The Pharmaceutical Market: USA - Product Thumbnail Image

The Pharmaceutical Market: USA

These highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting...

May 2012
FROM
The Pain Market Outlook to 2016 The Pain Market Outlook to 2016 - Product Thumbnail Image

The Pain Market Outlook to 2016

The heterogeneity of pain necessitates a wide range of analgesics with different modes of action and delivery methods As such, many different classes of drugs co-exist in the pain market However, despite...

July 2011
FROM
Competitor Analysis: G-CSF and GM-CSF Competitor Analysis: G-CSF and GM-CSF - Product Thumbnail Image

Competitor Analysis: G-CSF and GM-CSF

he present Competitive Intelligence Report about G-CSF and GM-CSF product portfolios and R&D pipelines provides a competitor evaluation in the field of G-CSF & GM-CSF branded products in regulated markets...

April 2013
FROM

Biosimilars in Developed Countries - Launch of Biosimilar mAbs in Europe and New Regulatory Pathways in the US to Spur Market Growth

GBI Research, the leading business intelligence provider, has released its latest report, “Biosimilars in Developed Countries - Launch of Biosimilar mAbs in Europe and New Regulatory Pathways in the...

July 2012
FROM
Competitor Analysis: Erythropoietin (EPO) Competitor Analysis: Erythropoietin (EPO) - Product Thumbnail Image

Competitor Analysis: Erythropoietin (EPO)

The Competitive Intelligence Report Erythropoietin (EPO) & Erythropoiesis Stimulating Agents (ESA) as of January 2011 in its 5th edition provides information on existing first and second generation...

January 2011
FROM

Australia Pharmaceuticals and Healthcare Report Q1 2011

Australia Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and regulatory bodies with independent...

December 2010
Global Biosimilars Industry Global Biosimilars Industry - Product Thumbnail Image

Global Biosimilars Industry

Biosimilar is a term used to describe officially approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusivity expiry on the innovator...

October 2012
FROM
Hospira Inc,(HSP) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages Hospira Inc,(HSP) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Hospira Inc,(HSP) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Hospira Inc (HSP), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

December 2012
FROM

Biosimilars Approval Pathways in the US and Europe - Development and Approval of Biosimilar mABs May Face Tough Regulatory Environment

Biosimilars Approval Pathways in the US and Europe - Development and Approval of Biosimilar mABs May Face Tough Regulatory Environment Summary GBI Research, the leading business intelligence provider,...

April 2011
FROM
Hospira Inc,(HSP) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages Hospira Inc,(HSP) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Hospira Inc,(HSP) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Hospira Inc (HSP), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

October 2013
FROM

Bone and Joint Infection Market to 2016 - Medical Imaging and PCR Methods to Facilitate Early Diagnosis and Treatment

Bone and Joint Infection Market to 2016 - Medical Imaging and PCR Methods to Facilitate Early Diagnosis and Treatment Summary GBI Research, the leading business intelligence provider, has released its...

February 2011
FROM

Australia Pharmaceuticals and Healthcare Report Q2 2009

Australia Pharmaceuticals and Healthcare Report provides independent forecasts and competitive intelligence on Australia's pharmaceuticals and healthcare industry In BMI’s Q209 Pharmaceutical Business...

April 2009

Australia Pharmaceuticals and Healthcare Report Q2 2011

The Australia Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and regulatory bodies with...

February 2011

Australia Pharmaceuticals and Healthcare Report Q1 2010

Australia Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and regulatory bodies with independent...

November 2009

Australia Pharmaceuticals and Healthcare Report Q2 2010

Business Monitor International's Australia Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments...

February 2010

Australia Pharmaceuticals and Healthcare Report Q4 2009

The Australia Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and regulatory bodies with...

August 2009

Australia Pharmaceuticals and Healthcare Report Q4 2010

Business Monitor International's Australia Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments...

August 2010
Loading Indicator